Driven by strong leadership
Senti Bio is led by seasoned professionals with a passion for building life-changing therapies. Chief Executive Officer and Co-founder, Dr. Tim Lu, is a pioneer in synthetic biology and has co-founded multiple therapeutics platform companies including Synlogic, Tango Therapeutics, Eligo Bioscience, BiomX and Engine Biosciences. Chief Technology Officer and Co-founder, Dr. Philip Lee, is an entrepreneur and technology platform builder specializing in cellular systems. Chief Financial Officer, Dr. Deborah Knobelman, is a proven life science executive with broad financial experience spanning senior leadership roles in biopharma companies and Wall Street. Chief Medical and Development Officer, Dr. Kanya Rajangam, is an experienced biotechnology executive with an extensive track record of successfully developing products across multiple modalities including allogeneic cell therapies.